Citadel Advisors
PBPH

Citadel Advisors’s Portfolio Building Block World Pharma and Biotech Index ETF PBPH Stock Holding History

Citadel Advisors’s Portfolio PBPH Stock Details PBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,513
Closed -$896K – 14841
2025
Q4 		$896K Buy
+35,513
New +$887K ﹤0.01% 7634

Other funds holding PBPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Citadel Advisors's PBPH Position: Q1 2026 in Review

Citadel Advisors sold out of Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) in Q1 2026, closing a stake of 35,513 shares — an estimated $896K sold.

Citadel Advisors first reported a position in PBPH in Q4 2025 and held it in 1 quarter. The position peaked at $896K in Q4 2025. 11 funds tracked by Wall St. Rank hold PBPH as of Q1 2026.

  • Citadel Advisors reported no remaining Portfolio Building Block World Pharma and Biotech Index ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 35,513 Portfolio Building Block World Pharma and Biotech Index ETF shares in Q1 2026, an estimated $896K.
  • Citadel Advisors first reported a position in Portfolio Building Block World Pharma and Biotech Index ETF in Q4 2025 and held it in 1 quarter.
  • Citadel Advisors's Portfolio Building Block World Pharma and Biotech Index ETF position peaked at $896K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Portfolio Building Block World Pharma and Biotech Index ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.